{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:15:22Z","timestamp":1762298122247,"version":"3.41.2"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.pharep.2014.05.005","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T01:17:42Z","timestamp":1401326262000},"page":"867-873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["mRNA of cytokines in bone marrow and bone biomarkers in response to propranolol in a nutritional growth retardation model"],"prefix":"10.1007","volume":"66","author":[{"given":"Deborah R.","family":"Tasat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian E.","family":"Lez\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Astort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.","family":"Pintos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa V.","family":"Macri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.pharep.2014.05.005_bib0005","first-page":"53","article-title":"Bone strength and the adolescent","volume":"13","author":"Root","year":"2002","journal-title":"Adolesc Med"},{"year":"1997","author":"Ferretti","series-title":"Biomechanical properties of bone","key":"10.1016\/j.pharep.2014.05.005_bib0010"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0015","first-page":"282","article-title":"Enanismo por desnutrici\u00f3n: cronodinamia de los procesos metab\u00f3licos en ratas","volume":"58","author":"Friedman","year":"1998","journal-title":"Medicina (B Aires)"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1079\/BJN20041331","article-title":"Bone status in an animal model of chronic sub-optimal nutrition: a morphometric, densitometric and mechanical study","volume":"93","author":"Boyer","year":"2005","journal-title":"Br J Nutr"},{"key":"10.1016\/j.pharep.2014.05.005_bib0025","first-page":"10","article-title":"Estudio comparativo morfom\u00e9trico, densitom\u00e9trico y biomec\u00e1nico de f\u00e9mur y mand\u00edbula en un modelo animal de enanismo por desnutrici\u00f3n","volume":"4","author":"Compagnucci","year":"2005","journal-title":"Rev Arg Osteol"},{"issue":"1","key":"10.1016\/j.pharep.2014.05.005_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0091-7435(92)90004-2","article-title":"Does a reduced fat diet cause retardation in child growth?","volume":"21","author":"Kaplan","year":"1992","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/07315724.1988.10720254","article-title":"Nutritional dwarfing: growth, dieting and fear of obesity","volume":"7","author":"Lifshitz","year":"1988","journal-title":"J Am Coll Nutr"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archpedi.1989.02150170035015","article-title":"Growth failure: a complication of dietary treatment of hypercholesterolemia","volume":"143","author":"Lifshitz","year":"1989","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/09637480120044129","article-title":"Growth deceleration and bone metabolism in nutritional dwarfing rats","volume":"52","author":"Friedman","year":"2001","journal-title":"Int J Food Sci Nutr"},{"issue":"7","key":"10.1016\/j.pharep.2014.05.005_bib0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.nutres.2006.06.018","article-title":"Decreased energy expenditure \u2013 an adaptive mechanism of nutritional growth retardation","volume":"26","author":"Friedman","year":"2006","journal-title":"Nutr Res"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000067177","article-title":"Effect of nutritional stress on the hypothalamo\u2013pituitary\u2013gonadal axis in the growing male rats","volume":"10","author":"Compagnucci","year":"2002","journal-title":"Neuroimmunomodulation"},{"unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. [No authors listed]. World Health Organ Tech Rep Ser 1994;843:1\u2013129 [review].","key":"10.1016\/j.pharep.2014.05.005_bib0060"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","article-title":"Leptin regulates bone formation via the sympathetic nervous system","volume":"111","author":"Takeda","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharep.2014.05.005_bib0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jemt.10121","article-title":"Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells","volume":"58","author":"Togari","year":"2002","journal-title":"Microsc Res Tech"},{"issue":"6","key":"10.1016\/j.pharep.2014.05.005_bib0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jor.1100090613","article-title":"Effects of propranolol on bone metabolism in the rat","volume":"9","author":"Minkowitz","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.pharep.2014.05.005_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874288200802010029","article-title":"Hypothalamic noradrenergic hyperactivity and detrimental bone status in an animal model of nutritional growth retardation","volume":"2","author":"Olivera","year":"2008","journal-title":"Open Nutr J"},{"issue":"11","key":"10.1016\/j.pharep.2014.05.005_bib0085","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1017\/S000711450811145X","article-title":"Improved bone status by \u03b2-blocker propranolol in an animal model of nutritional growth retardation","volume":"101","author":"Lez\u00f3n","year":"2009","journal-title":"Br J Nutr"},{"issue":"2","key":"10.1016\/j.pharep.2014.05.005_bib0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ortho\/25.2.101","article-title":"Bone remodeling","volume":"25","author":"Hill","year":"1998","journal-title":"Br J Orthod"},{"issue":"2 Suppl.","key":"10.1016\/j.pharep.2014.05.005_bib0095","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1016\/8756-3282(95)00180-L","article-title":"Role of cytokines in bone resorption","volume":"17","author":"Manolagas","year":"1995","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.pharep.2014.05.005_bib0100","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1365-2362.2011.02545.x","article-title":"Effects of inflammatory and anti-inflammatory cytokines on the bone","volume":"41","author":"Schett G:","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharep.2014.05.005_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00003086-198511000-00027","article-title":"The pathomechanics of osteoporoses","volume":"200","author":"Frost","year":"1985","journal-title":"Clin Orthop Relat Res"},{"issue":"12 Pt 2","key":"10.1016\/j.pharep.2014.05.005_bib0110","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1301\/nr.2007.dec.S147-S151","article-title":"Osteoporosis and inflammation","volume":"65","author":"Mundy","year":"2007","journal-title":"Nutr Rev"},{"issue":"12","key":"10.1016\/j.pharep.2014.05.005_bib0115","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.pharep.2014.05.005_bib0120","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI117995","article-title":"Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor","volume":"95","author":"Bellido","year":"1995","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.pharep.2014.05.005_bib0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1172\/JCI7094","article-title":"Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD","volume":"104","author":"Srivastava","year":"1999","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.pharep.2014.05.005_bib0130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbrc.2009.01.167","article-title":"Effects of continuous and pulsatile PTH treatments on rat bone marrow stromal cells","volume":"380","author":"Yang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.pharep.2014.05.005_bib0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-2007-996283","article-title":"Characterization of the beta-adrenergic receptor mediating secretion of parathyroid hormone","volume":"12","author":"Kukreja","year":"1980","journal-title":"Horm Metab Res"},{"unstructured":"National Institutes of Health (1985, revised 1990) Laboratory animal welfare. Public Health Service policy on humane care and use of laboratory animals by awardee institutions.","key":"10.1016\/j.pharep.2014.05.005_bib0140"},{"key":"10.1016\/j.pharep.2014.05.005_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.endonu.2011.09.006","article-title":"Effect of different propranolol doses on skeletal structural and mechanic efficiency in an animal model of growth retardation","volume":"59","author":"Lez\u00f3n","year":"2012","journal-title":"Endocrinol Nutr"},{"issue":"2","key":"10.1016\/j.pharep.2014.05.005_bib0150","first-page":"94","article-title":"Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis","volume":"8","author":"Bonnet","year":"2008","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.pharep.2014.05.005_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.110.167643","article-title":"Effects of propranolol on bone metabolism in spontaneously hypertensive rats","volume":"334","author":"Sato","year":"2010","journal-title":"JPET"},{"key":"10.1016\/j.pharep.2014.05.005_bib0160","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1734-1140(11)70620-X","article-title":"Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats","volume":"63","author":"Folwarczna","year":"2011","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.pharep.2014.05.005_bib0165","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11745-009-3302-x","article-title":"Plasma lipid levels of rats fed a diet containing pork fat as a source of lipids after splenic surgery","volume":"44","author":"Dinis","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.pharep.2014.05.005_bib0170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"11","key":"10.1016\/j.pharep.2014.05.005_bib0175","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/1521-1878(200011)22:11<970::AID-BIES3>3.0.CO;2-L","article-title":"A neuro endocrine regulation of bone remodeling","volume":"22","author":"Amling","year":"2000","journal-title":"Bioessays"},{"key":"10.1016\/j.pharep.2014.05.005_bib0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/oxfordjournals.epirev.a036281","article-title":"Epidemiology of osteoporosis and osteoporotic fractures","volume":"7","author":"Cummings","year":"1985","journal-title":"Epidemiol Rev"},{"issue":"4","key":"10.1016\/j.pharep.2014.05.005_bib0185","first-page":"358","article-title":"Osteoporosis and the role of diet","volume":"51","author":"Eaton-Evans","year":"1994","journal-title":"Br J Biomed Sci"},{"issue":"2","key":"10.1016\/j.pharep.2014.05.005_bib0190","first-page":"253","article-title":"Additive effects of dietary protein and energy deficiencies on diaphysis and bone tissue of rat femurs as determined by bending tests","volume":"41","author":"Ferretti","year":"1991","journal-title":"Acta Physiol Pharmacol Ther Latinoam"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0195","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/jn\/125.5.1283","article-title":"Rat serum osteocalcin is decreased by restriction of energy intake","volume":"125","author":"Ndiaye","year":"1995","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.pharep.2014.05.005_bib0200","first-page":"129","article-title":"Prevalence of protein\u2013energy malnutrition","volume":"36","author":"Keller","year":"1983","journal-title":"World Health Stat Quart"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02556258","article-title":"The matrix of endochondral bone differs from the matrix of intramembranous bone","volume":"49","author":"Scott","year":"1991","journal-title":"Calcif Tissue Int"},{"issue":"6937","key":"10.1016\/j.pharep.2014.05.005_bib0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jcb.240560312","article-title":"Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity","volume":"56","author":"Martin","year":"1994","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0220","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.1998.13.5.777","article-title":"Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells","volume":"13","author":"Nishimura","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.pharep.2014.05.005_bib0225","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0230","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","article-title":"Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors","volume":"182","author":"Udagawa","year":"1995","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.pharep.2014.05.005_bib0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL\u2013RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.pharep.2014.05.005_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism","volume":"32","author":"Kudo","year":"2003","journal-title":"Bone"},{"issue":"17","key":"10.1016\/j.pharep.2014.05.005_bib0245","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharep.2014.05.005_bib0250","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3892\/ijmm.2013.1269","article-title":"Temporal differential effects of proinflammatory cytokines on osteoclastogenesis","volume":"31","author":"Moon","year":"2013","journal-title":"Int J Mol Med"},{"issue":"24","key":"10.1016\/j.pharep.2014.05.005_bib0255","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Ohsugi","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"10.1016\/j.pharep.2014.05.005_bib0260","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","volume":"274","author":"O\u2019Brien","year":"1999","journal-title":"J Biol Chem"},{"issue":"4\u20135","key":"10.1016\/j.pharep.2014.05.005_bib0265","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6101(02)00027-8","article-title":"IL-6 in autoimmune disease and chronic inflammatory proliferative disease","volume":"13","author":"Ishihara","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"24","key":"10.1016\/j.pharep.2014.05.005_bib0270","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1073\/pnas.0500419102","article-title":"The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription","volume":"102","author":"Murray","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.pharep.2014.05.005_bib0275","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","article-title":"Macrophage deactivation by interleukin 10","volume":"174","author":"Bogdan","year":"1991","journal-title":"J Exp Med"},{"issue":"32","key":"10.1016\/j.pharep.2014.05.005_bib0280","doi-asserted-by":"crossref","first-page":"23301","DOI":"10.1016\/S0021-9258(18)50091-0","article-title":"Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10","volume":"267","author":"Bogdan","year":"1992","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharep.2014.05.005_bib0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.endonu.2010.03.003","article-title":"Neuronal LHRH system activity in an animal model of growth retardation","volume":"57","author":"Compagnucci","year":"2010","journal-title":"Endocrinol Nutr"},{"issue":"12","key":"10.1016\/j.pharep.2014.05.005_bib0290","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1359\/jbmr.060813","article-title":"Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10","volume":"21","author":"Shin","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0295","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.gastro.2004.06.013","article-title":"Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones","volume":"127","author":"Dresner-Pollak","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0300","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2004.11.069","article-title":"Parathyroid hormone and parathyroid hormone-related peptide, and their receptors","volume":"328","author":"Gensure","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharep.2014.05.005_bib0305","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.ki.5000148","article-title":"The renal NaC\/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone","volume":"69","author":"Bacic","year":"2006","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.pharep.2014.05.005_bib0310","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.crvi.2011.07.007","article-title":"Bone endocrine regulation of energy metabolism and male reproduction","volume":"334","author":"Karsenty","year":"2011","journal-title":"C R Biol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:32Z","timestamp":1752611732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.05.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1734114014002011"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.05.005","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA of cytokines in bone marrow and bone biomarkers in response to propranolol in a nutritional growth retardation model","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Urban & Partner Sp. z o.o.","name":"copyright","label":"Copyright"}]}}